Data-driven risk-based decisions Symposium

The Symposium

The Netherlands Comprehensive Cancer Organisation (IKNL) and the University of Twente (UT) cordially invite you to the symposium ‘Data-driven risk-based decisions’ that will be organized prior to the doctoral defense of Tom Hueting, working at Evidencio and PhD candidate at the University of Twente, where he will defend his thesis: ‘Developing, validating, and evaluating clinical prediction models in breast and prostate cancer’. With this symposium, the (IKNL and the UT wish to provide insight into the value of 'real world' data in supporting decisions in oncological care.

The programme

A selection of topics covered during the symposium:

• Necessary translation of predictions to patient management via risk thresholds to health outcomes and costs
• Interpretation of prediction models; the limitations and the opportunities
• Evidencio: an online platform for making prediction models available, dissemination, validation and implementation.

 Key-players in the field of research and clinical practice will guide you through these different subjects.

• Prof.dr. S. Siesling, clinical epidemiologist, IKNL/ Professor of Outcomes Research and Personalised Cancer Care, University of Twente (UT)
• Prof. dr. M.A.W. Merkx, chairman of the board IKNL, Professor Trends & Patterns in Cancer and Care, IQ health, Radboudumc
• Dr.ir. H. Koffijberg, Associate Professor and chair of the department of Health Technology and Services Research
• Prof. dr. E.W. Steyerberg, Professor of clinical biostatistics and medical decision-making/ Department head Biomedical Data Sciences, LUMC/Erasmus MC
• Prof. dr. ir. A.L.A.J. Dekker, Professor Clinical Data Science, MUMC and medical physicist, MAASTRO
• Prof. dr. J.E.A. Portielje, Professor of internal oncology, (Leids Universitair Medisch Centrum (LUMC)
• Prof. dr. H.G. van der Poel, Professor of image-guided surgical urology, Antoni van Leeuwenhoek (AvL)
• Dr. M.C. van Maaren, postdoctoral researcher, IKNL/UT
• Dr. R.G. Pleijhuis, internist-allergologist/immunologist, UMCG and Chief Medical Officer, Evidencio

Subsequently at 16.45 hrs. Tom Hueting will defend his thesis.

For whom

The symposium is of interest for researchers, care providers, general practitioners, nurse specialists, nurses in oncological care, board members of patient associations and directors, managers and policy officers

We have a limit of 100 live attendees at the TechMed Centre, so register now to ensure your seat. 

Registration

To participate in this symposium you need to register yourself. You can do this via this link. Although this is a free event, please note that registration for this event is not obligation-free. If you cannot attend the event for which you have already registered, we kindly ask that you let us know by sending an email to l.bergmans@iknl.nl.

Organisation